Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $151.22 Million |
|---|---|
| Enterprise Value | $140.92 Million |
| Earnings per Share | $-0.02 |
| Beta | 0.77 |
| Outstanding Shares | 432,069,786 |
| P/E Ratio | -24.85 |
|---|---|
| PEG | -26.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 7.87 |
| Enterprise Value to EBIT | -4.82 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Starpharma Holdings Limited is a global biopharmaceutical firm dedicated to the investigation, advancement, and marketing of its proprietary dendrimer-based products for pharmaceutical, life science, and other diverse applications. Among...